DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3031% below fair value
$81.61−1.72 (-2.06%)
Close on Nov 16, 2026Market cap $30.44BP/E 32.1Yield –
DexCom profit margin
Profit margin (net margin) is net income as a percentage of revenue.
DexCom's profit margin for the twelve months ending Sep 30, 2026 was 19.4%. For fiscal 2025 it was 17.9%, against 14.3% the year before. The highest annual figure on record is 28.5% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.9% | +3.7 |
| FY2024 | Dec 31, 2024 | 14.3% | −0.7 |
| FY2023 | Dec 31, 2023 | 14.9% | +3.2 |
| FY2022 | Dec 31, 2022 | 11.7% | +2.9 |
| FY2021 | Dec 31, 2021 | 8.9% | −19.7 |
| FY2020 | Dec 31, 2020 | 28.5% | +21.7 |
| FY2019 | Dec 31, 2019 | 6.8% | +19.2 |
| FY2018 | Dec 31, 2018 | -12.3% | −5.3 |
| FY2017 | Dec 31, 2017 | -7.0% | +4.5 |
| FY2016 | Dec 31, 2016 | -11.4% | +2.9 |
| FY2015 | Dec 31, 2015 | -14.3% | −5.7 |
| FY2014 | Dec 31, 2014 | -8.6% | +10.0 |
| FY2013 | Dec 31, 2013 | -18.6% | +35.9 |
| FY2012 | Dec 31, 2012 | -54.6% | +4.0 |
| FY2011 | Dec 31, 2011 | -58.6% | +55.0 |
| FY2010 | Dec 31, 2010 | -113.6% | +66.7 |
| FY2009 | Dec 31, 2009 | -180.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 20.5% | −3.0 |
| Q2 FY2026 | Jun 30, 2026 | 19.0% | +3.5 |
| Q1 FY2026 | Mar 31, 2026 | 16.7% | +6.6 |
| Q4 FY2025 | Dec 31, 2025 | 21.2% | +7.6 |
| Q3 FY2025 | Sep 30, 2025 | 23.5% | +9.9 |
| Q2 FY2025 | Jun 30, 2025 | 15.5% | +1.3 |
| Q1 FY2025 | Mar 31, 2025 | 10.2% | −5.7 |
| Q4 FY2024 | Dec 31, 2024 | 13.6% | −11.2 |
| Q3 FY2024 | Sep 30, 2024 | 13.5% | +1.2 |
| Q2 FY2024 | Jun 30, 2024 | 14.3% | +1.0 |
| Q1 FY2024 | Mar 31, 2024 | 15.9% | +9.3 |
| Q4 FY2023 | Dec 31, 2023 | 24.8% | +13.5 |
| Q3 FY2023 | Sep 30, 2023 | 12.4% | −0.8 |
| Q2 FY2023 | Jun 30, 2023 | 13.3% | +6.0 |
| Q1 FY2023 | Mar 31, 2023 | 6.6% | −8.9 |
| Q4 FY2022 | Dec 31, 2022 | 11.3% | +12.0 |
| Q3 FY2022 | Sep 30, 2022 | 13.1% | −0.3 |
| Q2 FY2022 | Jun 30, 2022 | 7.3% | −5.9 |
| Q1 FY2022 | Mar 31, 2022 | 15.5% | +4.3 |
| Q4 FY2021 | Dec 31, 2021 | -0.8% | −73.1 |
| Q3 FY2021 | Sep 30, 2021 | 13.4% | −1.0 |
| Q2 FY2021 | Jun 30, 2021 | 13.2% | +2.9 |
| Q1 FY2021 | Mar 31, 2021 | 11.2% | +6.3 |
| Q4 FY2020 | Dec 31, 2020 | 72.3% | +52.3 |
| Q3 FY2020 | Sep 30, 2020 | 14.4% | +2.9 |
| Q2 FY2020 | Jun 30, 2020 | 10.2% | +13.4 |
| Q1 FY2020 | Mar 31, 2020 | 4.9% | +14.5 |
| Q4 FY2019 | Dec 31, 2019 | 20.0% | +73.2 |
| Q3 FY2019 | Sep 30, 2019 | 11.6% | −5.9 |
| Q2 FY2019 | Jun 30, 2019 | -3.1% | −15.6 |
| Q1 FY2019 | Mar 31, 2019 | -9.6% | +3.5 |
| Q4 FY2018 | Dec 31, 2018 | -53.2% | −48.9 |
| Q3 FY2018 | Sep 30, 2018 | 17.5% | +18.6 |
| Q2 FY2018 | Jun 30, 2018 | 12.5% | +10.8 |
| Q1 FY2018 | Mar 31, 2018 | -13.1% | +16.2 |
| Q4 FY2017 | Dec 31, 2017 | -4.3% | +0.1 |
| Q3 FY2017 | Sep 30, 2017 | -1.1% | – |
| Q2 FY2017 | Jun 30, 2017 | 1.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -29.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -4.3% | – |
See a number that looks wrong?